AMPH icon

Amphastar Pharmaceuticals

207 hedge funds and large institutions have $839M invested in Amphastar Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 80 increasing their positions, 81 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

21% less capital invested

Capital invested by funds: $1.06B → $839M (-$223M)

40% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 35

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
207
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.77M
Puts
$935K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
151
$182K
152
$149K
153
$144K
154
$137K
155
$125K
156
$112K
157
$89K
158
$86K
159
$80K
160
$75K
161
$70K
162
$63.7K
163
$61K
164
$53K
165
$50K
166
$38.1K
167
$35K
168
$33K
169
$28K
170
$20K
171
$19K
172
$17.1K
173
$17K
174
$16K
175
$13K